FDA Inspection 1061388 — Celltrion Inc.

Celltrion Inc. — FEI 3005241015

The FDA completed an inspection of Celltrion Inc. on July 17, 2018 in Yeonsu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 17, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yeonsu (Korea (the Republic of))